Mislabeled pork egg rolls are recalled

Jun 19, 2007

The U.S. Food Safety and Inspection Service has announced the recall of 2,762 pounds of pork egg rolls because they are mislabeled.

The Pampanga Foods Co. Inc. of Anaheim, Calif., issued the recall because the product label does not identify egg and bleached wheat flour -- both known allergens -- as ingredients, thereby posing a health risk to individuals sensitive to those allergens.

Recalled were 14-ounce packages of "Pampanga Pork (Cured) Lumpia Egg Roll, Shanghai Brand." Each label bears the establishment number "EST. 0405A" inside the USDA mark of inspection.

The recalled pork egg roll products were distributed to retail establishments and distribution warehouses in California, Florida, New Jersey and New York.

Consumers with questions can contact company Sales Manager Hector Mariano at 714-292-6880.

Copyright 2007 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Study puts over 2,400 food scares under the microscope

Mar 22, 2011

(PhysOrg.com) -- As the increasing number food scares causes consumers to question the safety of everyday food items, researchers at Queen's University Belfast have completed the first ever analysis of all the food recalls ...

For US soldiers, a healthy food revolution

Jan 30, 2011

Pizzas, sodas and doughnuts are off the menu at some US Army bases as new recruits are being weaned off fast food for healthier fare, which the military believes will make them better soldiers.

How to... eat for health

Feb 15, 2009

Fixing these common mistakes will help many people be healthier, says Dr. Phillip Snider, a family physician in Virginia Beach, Va.

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

FDA proposes first regulations for e-cigarettes

The federal government wants to prohibit sales of electronic cigarettes to minors and require approval for new products and health warning labels under regulations being proposed by the Food and Drug Administration.

Rising role seen for health education specialists

(HealthDay)—A health education specialist can help family practices implement quality improvement projects with limited additional financial resources, according to an article published in the March/April ...

When things get glassy, molecules go fractal

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...

FCC to propose pay-for-priority Internet standards

The Federal Communications Commission is set to propose new open Internet rules that would allow content companies to pay for faster delivery over the so-called "last mile" connection to people's homes.

SK Hynix posts Q1 surge in net profit

South Korea's SK Hynix Inc said Thursday its first-quarter net profit surged nearly 350 percent from the previous year on a spike in sales of PC memory chips.